Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS).

Trial Profile

Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS).

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Ethyl eicosapentaenoic acid (Primary) ; Pravastatin; Simvastatin
  • Indications Cardiovascular disorders; Coronary artery disease; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms JELIS
  • Most Recent Events

    • 12 Jan 2010 Actual end date (Nov 2004) and Actual initiation date (Nov 1996)added as reported by ClinicalTrials.gov.
    • 27 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top